[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335298-105":59,"doc-detail-335298-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-blood-lipid-markers-of-docetaxel-treatment-in-prostate-cancer-patients","Identification of blood lipid markers of docetaxel treatment in prostate cancer patients","","Docetaxel is widely used to treat castration-resistant prostate cancer, but resistance limits long-term benefit. This study evaluates lipid species in whole blood as minimally invasive clinical markers for docetaxel resistance. Qualitative lipidomics using liquid chromatography-tandem mass spectrometry profiles lipids in prostate cancer cells exposed to docetaxel and in patient blood samples collected before, during, and after treatment. Mean decrease accuracy and univariate ROC analyses identify altered lipids linked to ether-linked phosphatidylcholines, lysophosphatidylcholine, diacylglycerols, ceramides, hexosylceramides, and sphingomyelins.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-blood-lipid-markers-of-docetaxel-treatment-in-prostate-cancer-patients/335298/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-blood-lipid-markers-of-docetaxel-treatment-in-prostate-cancer-patients/335298.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are blood lipid markers considered for docetaxel resistance monitoring?","Question",{"text":112,"@type":113},"Many prostate cancer patients develop resistance to docetaxel, and blood-based clinical markers are less invasive than biopsies. Lipid alterations are also linked to cancer progression, supporting their use for monitoring treatment outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What method was used to analyze lipids in this study?",{"text":117,"@type":113},"The study used qualitative lipidomics with liquid chromatography-tandem mass spectrometry (LC–MS/MS) to assess lipid composition in both docetaxel-exposed prostate cancer cells and whole blood samples.",{"name":119,"@type":110,"acceptedAnswer":120},"Which lipid classes were altered after docetaxel treatment?",{"text":121,"@type":113},"Model results indicated alterations in ether-linked phosphatidylcholines, lysophosphatidylcholine, diacylglycerols, ceramides, hexosylceramides, and sphingomyelins, along with changes related to sphingolipid signaling and glycerophospholipid metabolism.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335298,1790119656,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIdentification of blood lipid markers of docetaxel treatment in prostate cancer patients  \nMorgan C. Finnerty1, Franklin E. Leach III2,3, Yousef Zakharia4,5, Kenneth G. Nepple6, Michael G. Bartlett1, Michael D. Henry5,7 & Brian S. Cummings1,8,9,10􀀍  \nDocetaxel is commonly used for treatment of castration-resistant prostate cancer. Unfortunately, many prostate cancer patients develop resistance to docetaxel. Clinical markers less invasive than biopsies, such as blood samples, would be ideal for monitoring and predicting patient treatment outcomes to docetaxel. Lipid alterations are often associated with the progression of many cancers, including prostate cancer. This study investigated the use of lipids from whole blood as clinical markers for docetaxel resistance in a small cohort of patients with prostate cancer. Qualitative lipidomics was performed by liquid chromatography-tandem mass spectrometry to assess the lipid composition of prostate cancer cells exposed to docetaxel as well as whole blood from prostate cancer patients before, during and after docetaxel treatment. Three patients had castration resistant prostate cancer, three had castration sensitive prostate cancer, and four had de novo prostate cancer during the extent of  \nthe study. Mean decrease accuracy and classical univariate receiving operating characteristic curve analyses were performed to identify potential biomarkers. In total, 245 and 221 altered lipids were identified from a second stage of mass spectrometry analysis of prostate cancer cells and clinical blood samples, respectively. Both models indicated that docetaxel treatment altered ether-linked phosphatidylcholines, lysophosphatidylcholine, diacylglycerols, ceramides, hexosylceramides, and sphingomyelins. The results also indicated several lipid changes were associated with sphingolipid signaling and metabolism, and glycerophospholipid metabolism. Collectively, these data suggest the potential usage of identified lipid species as indicators of docetaxel resistance in prostate cancer.  \nKeywords Docetaxel, Prostate cancer, Lipidomics, Drug resistance, Biomarker, Clinical  \nAbbreviations  \nACN Acetonitrile  \nADT Androgen deprivation therapy AGC Automatic gain control  \nAR Androgen receptor  \nAUC Area under the curve  \nCAR Acylcarnitine  \nCer Ceramide  \nCRPC Castration-resistant prostate cancer  \nDG Diacylglycerol  \nDMSO Dimethyl sulfoxide ER Endoplasmic reticulum  \nESI Electrospray ionization  \nFA Fatty acyl  \n1Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA 30602, USA.  \n2Department of Chemistry, University of Georgia, Athens, GA 30602, USA. 3Complex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA. 4Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA 52242, USA. 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 52242, USA. 6Department of Urology, University of Iowa, Iowa City, IA 52242, USA. 7Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA. 8Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48202, USA. 9Interdisciplinary Toxicology Program, University of Georgia, Athens, GA 30602, USA. 10College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI 48201, USA. 􀀍 email: [BrianCummings@wayne.edu](BrianCummings@wayne.edu)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nFBS Fetal bovine serum  \nFC Fold change  \nFDR False discovery rate  \nGL Glycerolipid  \nGM Glycerophospholipid metabolism  \nGP Glycerophospholipid  \nGU-MER Genito-urologic molecular epidemiology resource Hex2Cer Dihexosylceramide  \nHexCer Hexosylceramide  \nHPLC High-performance liquid chromatography H2O2 Hydrogen peroxide  \nIDA Information dependent acquisition  \nLC-MS L","cbCaioU9d2AD71HP","https://ap.wps.com/l/cbCaioU9d2AD71HP","pdf",3332339,"English","# Background\n## Docetaxel use and resistance in prostate cancer\n# Methods\n## Qualitative lipidomics with LC–MS/MS\n## Patient groups and sampling timeline\n## Biomarker identification using ROC and accuracy metrics\n# Results\n## Docetaxel-associated lipid alterations in cells and blood\n## Lipid signaling and metabolism pathways\n# Conclusion\n## Potential blood lipid indicators of docetaxel resistance","[{\"question\":\"Why are blood lipid markers considered for docetaxel resistance monitoring?\",\"answer\":\"Many prostate cancer patients develop resistance to docetaxel, and blood-based clinical markers are less invasive than biopsies. Lipid alterations are also linked to cancer progression, supporting their use for monitoring treatment outcomes.\"},{\"question\":\"What method was used to analyze lipids in this study?\",\"answer\":\"The study used qualitative lipidomics with liquid chromatography-tandem mass spectrometry (LC–MS/MS) to assess lipid composition in both docetaxel-exposed prostate cancer cells and whole blood samples.\"},{\"question\":\"Which lipid classes were altered after docetaxel treatment?\",\"answer\":\"Model results indicated alterations in ether-linked phosphatidylcholines, lysophosphatidylcholine, diacylglycerols, ceramides, hexosylceramides, and sphingomyelins, along with changes related to sphingolipid signaling and glycerophospholipid metabolism.\"}]","Identification of blood lipid markers of docetaxel treatment in prostate cancer patients | PDF",1790010420,48]